Search

everythinglearnresearchcommunity

for

Search:↓

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Keratin genes change gradually during skin cell development and should be used carefully as biomarkers.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Tiny RNA molecules help control the growth of plant hairs.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

Elderly in South India commonly suffer from skin issues like wrinkles, dryness, and infections, needing better skin care education.

Kidney transplant patients often have skin issues, mainly infections.

Scientists can now create skin with hair by reprogramming cells in wounds.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Hair transplant surgeries can be improved by preserving follicles in a special solution, and surgeries done at outpatient facilities are more profitable than those at hospitals.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

A blood pressure drug, diltiazem, may also help treat influenza.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.